Cellebration Life Sciences announced it raised $2.8 Million in an amended filing from an offering of $20 Million
Aug 21, 2023•almost 2 years ago
Amount Raised
$2.8 Million
Round Type
seed
PhoenixBiotechnology
Company Information
Company
Cellebration Life Sciences, Inc.
Location
12601 N. CAVE CREEK ROAD, SUITE 111
Phoenix, Arizona, United States
About
Cellebration Life Sciences is a pre-clinical trial R&D company focused on a permanent curative treatment for Type 2 Diabetes through the use of Stem Cells.